Effect of cisternal sulfamidase delivery in MPS IIIA Huntaway dogs—A proof of principle study
- 1 December 2009
- journal article
- research article
- Published by Elsevier BV in Molecular Genetics and Metabolism
- Vol. 98 (4), 383-392
- https://doi.org/10.1016/j.ymgme.2009.07.013
Abstract
No abstract availableThis publication has 41 references indexed in Scilit:
- Enzyme Replacement Improves Ataxic Gait and Central Nervous System Histopathology in a Mouse Model of Metachromatic LeukodystrophyMolecular Therapy, 2009
- Intrathecal enzyme replacement therapy in a patient with mucopolysaccharidosis type I and symptomatic spinal cord compressionAmerican Journal of Medical Genetics Part A, 2008
- Immune tolerance improves the efficacy of enzyme replacement therapy in canine mucopolysaccharidosis IJCI Insight, 2008
- Intrathecal enzyme replacement therapy: Successful treatment of brain disease via the cerebrospinal fluidMolecular Genetics and Metabolism, 2007
- Newborn screening for lysosomal storage disordersMolecular Genetics and Metabolism, 2006
- Characterization of Sulfated Oligosaccharides in Mucopolysaccharidosis Type IIIA by Electrospray Ionization Mass SpectrometryAnalytical Chemistry, 2006
- Direct Comparison of Measures of Endurance, Mobility, and Joint Function During Enzyme-Replacement Therapy of Mucopolysaccharidosis VI (Maroteaux-Lamy Syndrome): Results After 48 Weeks in a Phase 2 Open-Label Clinical Study of Recombinant Human N-Acetylgalactosamine 4-SulfatasePublished by American Academy of Pediatrics (AAP) ,2005
- Intrathecal enzyme replacement therapy reduces lysosomal storage in the brain and meninges of the canine model of MPS IMolecular Genetics and Metabolism, 2004
- Immune tolerance after long-term enzyme-replacement therapy among patients who have mucopolysaccharidosis IThe Lancet, 2003
- Treatment of MPS VII (Sly disease) by allogeneic BMT in a female with homozygous A619V mutationBone Marrow Transplantation, 1998